Bit Capital Gmb H Janux Therapeutics, Inc. Transaction History

Bit Capital Gmb H

  • $1.26 Trillion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 12, 2025
SELL
$35.29 - $50.26 $1.1 Million - $1.57 Million
-31,223 Closed
0 $0
Q2 2024

Feb 12, 2025
SELL
$35.12 - $64.78 $3,511 - $6,478
-100 Reduced 0.32%
31,223 $1.31 Billion
Q1 2024

Feb 12, 2025
BUY
$7.93 - $49.75 $248,391 - $1.56 Million
31,323 New
31,323 $1.18 Billion

Others Institutions Holding JANX

# of Institutions
181
Shares Held
40.3M
Call Options Held
115K
Put Options Held
681K
View Full List

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.5B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email